SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Research and Markets: Global Age-Related Macular Degeneration (AMD) Market 2014-2018
[July 04, 2014]

Research and Markets: Global Age-Related Macular Degeneration (AMD) Market 2014-2018


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/wszsld/global) has announced the addition of the "Global Age-Related Macular Degeneration (AMD) Market 2014-2018" report to their offering.

AMD (News - Alert) is defined as the deterioration of the eye's macula. The macula is a small area in the retina that is responsible for central vision. The exact etiology of AMD is unknown. There are two types of macular degeneration: wet and dry. Wet AMD occurs when tiny abnormal blood vessels begin growing behind the retina toward the macula.

Dry AMD occurs when small, yellowish deposits called drusen begin accumulating beneath the macula. While a number of treatments are available for wet AMD, there is no treatment available at the moment for dry AMD.

The analysts forecast the Global AMD market will grow at a CAGR of 6.62 percent over the period 2013-2018

Key Topics Covered:

01. Executive Summary


02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Product Portfolio of Current AMD Therapies

08. Clinical Pipeline Portfolio

09. Rate of Incidence and Prevalence

10. Market Segmentation by Types

11. Geographical Segmentation

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

20. Other Reports in this Series

Companies Mentioned:

  • Acucela Inc.
  • Advanced Cell Technology Inc.
  • Alexion Pharmaceuticals Inc.
  • Alimera Sciences Inc.
  • Allergen Inc.
  • Allergo Opthalmics LLC
  • Avalanche Biotechnologies Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline plc
  • Icon Bioscience Inc.
  • Intellect (News - Alert) Neurosciences Inc.
  • Lpath Inc.
  • Neurotech Pharmaceuticals Inc.
  • Novartis AG
  • OSI Pharmaceuticals Inc.
  • Opthotech Corp.
  • Oxigene Inc.
  • PanOptica Inc.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Santen Pharmaceutical Co. Ltd.
  • StemCells Inc.
  • Synthetic Biologics Inc.
  • Thrombogenics NV
  • Valeant Pharmaceuticals International Inc.

For more information visit http://www.researchandmarkets.com/research/wszsld/global


[ Back To TMCnet.com's Homepage ]






Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2017 Technology Marketing Corporation. All rights reserved | Privacy Policy